KAPA Stock Analysis: Buy, Sell, or Hold?
KAPA - Kairos Pharma, Ltd.
$0.66
0.00 (-0.06%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Dec 03, 2025
0d
Get Alerted When KAPA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called KAPA this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: KAPA is down 12.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: KAPA is down 12.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: KAPA is currently trading at $0.66, which is considered oversold relative to its 30-day fair value range of $0.71 to $0.87.
Technical Outlook: Technically, KAPA is in a strong downtrend. Immediate support is located at $0.64, while resistance sits at $0.90.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.33 (+1153.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, KAPA is in a strong downtrend. Immediate support is located at $0.64, while resistance sits at $0.90.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.33 (+1153.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.71 -
$0.87
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Protect Your Profits
Holding KAPA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1153.5% below Wall St target ($8.33)
- WARNING: Recommendation downgraded due to -12.8% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$0.71 -
$0.87
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.64
Resistance Level
$0.90
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-2.01
Wall Street Target
$8.33
(+1153.5%)
Last updated: January 30, 2026 5:39 PM ET
Data refreshes hourly during market hours. Next update: 6:39 PM
Data refreshes hourly during market hours. Next update: 6:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KAPA showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$56 | 59 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$210 | 57 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 62 BUY |
|
ARVN
Arvinas Inc |
BUY
21 analysts |
$13 | 63 BUY |
Advanced KAPA Option Strategies
Professional options setups generated by AI based on today's KAPA price and gamma walls.
